U.S. Healthcare Bioconvergence Market, 2026-2033

The healthcare bioconvergence market in the United States is expected to reach a projected revenue of US$ 60,994.1 million by 2033. A compound annual growth rate of 4.9% is expected of the United States healthcare bioconvergence market from 2026 to 2033.